ID

12863

Description

Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02424045

Link

https://clinicaltrials.gov/show/NCT02424045

Keywords

Versions (1)
  1. 1/3/16 1/3/16 -
Uploaded on

January 3, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility T-cell Lymphoma NCT02424045

English

Eligibility T-cell Lymphoma NCT02424045

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histologically proven aggressive t-cell non-hodgkin's lymphoma (nhl)
Description

t-cell non-hodgkins lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0079772
2. age 18 -75 years
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
3. ann arbor stage ii, iii and iv (appendix a)
Description

Lymphoma stage

Data type

boolean

Alias
UMLS CUI [1]
C1272836
4. relapsed or refractory cases to previous treatments
Description

relapse

Data type

boolean

Alias
UMLS CUI [1]
C0277556
5. performance status (ecog) ≤ 2 (appendix b)
Description

ecog

Data type

boolean

Alias
UMLS CUI [1]
C1520224
6. at least one or more bidimensionally measurable lesion(s)
Description

lesion measurable

Data type

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C1513040
≥ 2 cm by conventional ct
Description

conventional tomography

Data type

boolean

Alias
UMLS CUI [1]
C2137222
≥ 1 cm by spiral ct
Description

spiral ct

Data type

boolean

Alias
UMLS CUI [1]
C0860888
skin lesion (photographs should be taken) ≥ 2 cm
Description

skin lesion

Data type

boolean

Alias
UMLS CUI [1]
C0037284
measurable lesion by physical examination ≥ 2 cm
Description

lesion measurable

Data type

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C1513040
7. cardiac ejection fraction ≥ 50 % as measured by muga or 2decho without clinically significant abnormalities
Description

cardiac ejection fraction; muga abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0232174
UMLS CUI [2]
C0853480
8. adequate renal function: serum creatinine level < 2 mg/dl (177 μmol/l)
Description

renal function adequate

Data type

boolean

Alias
UMLS CUI [1,1]
C0232804
UMLS CUI [1,2]
C0205411
9. adequate liver functions: transaminase (ast/alt) < 3 x upper normal value (or < 5 x uln in the presence of dlbcl involvement of the liver), bilirubin < 2 x upper normal value (or < 5 x uln in the presence of ptcl involvement of the liver)
Description

liver function adequate

Data type

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0205411
10. adequate bm functions: hemoglobin ≥ 9 g/dl absolute neutrophil count (anc) ≥ 1,500/μl and platelet count ≥ 75,000/μl, unless abnormalities are due to bone marrow involvement by lymphoma
Description

organ function bone marrow adequate

Data type

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0005953
UMLS CUI [1,3]
C0205411
11. a negative serum or urine pregnancy test prior to treatment must be available both for pre-menopausal women and for women who are < 1years after the onset of menopause.
Description

negative pregnancy test

Data type

boolean

Alias
UMLS CUI [1]
C0427780
12. informed consent
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. alk-positive anaplastic large cell lymphoma and sezary syndrome.
Description

alk-positive anaplastic large cell lymphoma; sezary syndrome

Data type

boolean

Alias
UMLS CUI [1]
C1332079
UMLS CUI [2]
C0036920
2. cns or testis involvement.
Description

Site of involvement Central Nervous System testis

Data type

boolean

Alias
UMLS CUI [1,1]
C0449683
UMLS CUI [1,2]
C3714787
UMLS CUI [1,3]
C0039597
3. previously treated with the regimen containing bendamustine or platinum agents.
Description

bendamustine; platinum agents

Data type

boolean

Alias
UMLS CUI [1]
C0525079
UMLS CUI [2]
C3536920
4. any other malignancies within the past 5 years except curatively treated non-melanoma skin cancer or in situ carcinoma of cervix uteri
Description

Comorbidity Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0006826
5. pregnant or lactating women, women of childbearing potential not employing adequate contraception
Description

pregnancy; lactating

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
6. other serious illness or medical conditions
Description

Comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0009488
7. unstable cardiac disease despite treatment, myocardial infarction within 6 months prior to study entry
Description

cardiac disease

Data type

boolean

Alias
UMLS CUI [1]
C0018799
8. history of significant neurologic or psychiatric disorders including dementia or seizures
Description

Mental disorders; dementia

Data type

boolean

Alias
UMLS CUI [1]
C0004936
UMLS CUI [2]
C0497327
9. active uncontrolled infection (viral, bacterial or fungal infection)
Description

comorbidity infection

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C3714514
10. other serious medical illnesses
Description

comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0009488
11. known hypersensitivity to any of the study drugs or its ingredients
Description

hypersensitivity Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
12. concomitant administration of any other experimental drug under investigation, or concomitant chemotherapy, hormonal therapy, or immunotherapy.
Description

concomitant medication

Data type

boolean

Alias
UMLS CUI [1]
C2347852
Back to the top of the page

Similar models

Eligibility T-cell Lymphoma NCT02424045

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
t-cell non-hodgkins lymphoma
Item
1. histologically proven aggressive t-cell non-hodgkin's lymphoma (nhl)
boolean
C0079772 (UMLS CUI [1])
age
Item
2. age 18 -75 years
boolean
C0001779 (UMLS CUI [1])
Lymphoma stage
Item
3. ann arbor stage ii, iii and iv (appendix a)
boolean
C1272836 (UMLS CUI [1])
relapse
Item
4. relapsed or refractory cases to previous treatments
boolean
C0277556 (UMLS CUI [1])
ecog
Item
5. performance status (ecog) ≤ 2 (appendix b)
boolean
C1520224 (UMLS CUI [1])
lesion measurable
Item
6. at least one or more bidimensionally measurable lesion(s)
boolean
C0221198 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
conventional tomography
Item
≥ 2 cm by conventional ct
boolean
C2137222 (UMLS CUI [1])
spiral ct
Item
≥ 1 cm by spiral ct
boolean
C0860888 (UMLS CUI [1])
skin lesion
Item
skin lesion (photographs should be taken) ≥ 2 cm
boolean
C0037284 (UMLS CUI [1])
lesion measurable
Item
measurable lesion by physical examination ≥ 2 cm
boolean
C0221198 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
cardiac ejection fraction; muga abnormal
Item
7. cardiac ejection fraction ≥ 50 % as measured by muga or 2decho without clinically significant abnormalities
boolean
C0232174 (UMLS CUI [1])
C0853480 (UMLS CUI [2])
renal function adequate
Item
8. adequate renal function: serum creatinine level < 2 mg/dl (177 μmol/l)
boolean
C0232804 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
liver function adequate
Item
9. adequate liver functions: transaminase (ast/alt) < 3 x upper normal value (or < 5 x uln in the presence of dlbcl involvement of the liver), bilirubin < 2 x upper normal value (or < 5 x uln in the presence of ptcl involvement of the liver)
boolean
C0232741 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
organ function bone marrow adequate
Item
10. adequate bm functions: hemoglobin ≥ 9 g/dl absolute neutrophil count (anc) ≥ 1,500/μl and platelet count ≥ 75,000/μl, unless abnormalities are due to bone marrow involvement by lymphoma
boolean
C0678852 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0205411 (UMLS CUI [1,3])
negative pregnancy test
Item
11. a negative serum or urine pregnancy test prior to treatment must be available both for pre-menopausal women and for women who are < 1years after the onset of menopause.
boolean
C0427780 (UMLS CUI [1])
informed consent
Item
12. informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
alk-positive anaplastic large cell lymphoma; sezary syndrome
Item
1. alk-positive anaplastic large cell lymphoma and sezary syndrome.
boolean
C1332079 (UMLS CUI [1])
C0036920 (UMLS CUI [2])
Site of involvement Central Nervous System testis
Item
2. cns or testis involvement.
boolean
C0449683 (UMLS CUI [1,1])
C3714787 (UMLS CUI [1,2])
C0039597 (UMLS CUI [1,3])
bendamustine; platinum agents
Item
3. previously treated with the regimen containing bendamustine or platinum agents.
boolean
C0525079 (UMLS CUI [1])
C3536920 (UMLS CUI [2])
Comorbidity Malignant Neoplasms
Item
4. any other malignancies within the past 5 years except curatively treated non-melanoma skin cancer or in situ carcinoma of cervix uteri
boolean
C0009488 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
pregnancy; lactating
Item
5. pregnant or lactating women, women of childbearing potential not employing adequate contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Comorbidity
Item
6. other serious illness or medical conditions
boolean
C0009488 (UMLS CUI [1])
cardiac disease
Item
7. unstable cardiac disease despite treatment, myocardial infarction within 6 months prior to study entry
boolean
C0018799 (UMLS CUI [1])
Mental disorders; dementia
Item
8. history of significant neurologic or psychiatric disorders including dementia or seizures
boolean
C0004936 (UMLS CUI [1])
C0497327 (UMLS CUI [2])
comorbidity infection
Item
9. active uncontrolled infection (viral, bacterial or fungal infection)
boolean
C0009488 (UMLS CUI [1,1])
C3714514 (UMLS CUI [1,2])
comorbidity
Item
10. other serious medical illnesses
boolean
C0009488 (UMLS CUI [1])
hypersensitivity Investigational New Drugs
Item
11. known hypersensitivity to any of the study drugs or its ingredients
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
concomitant medication
Item
12. concomitant administration of any other experimental drug under investigation, or concomitant chemotherapy, hormonal therapy, or immunotherapy.
boolean
C2347852 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial